Cite
Tonello M, Baratti D, Sammartino P, et al. Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol. 2021;doi: 10.1245/s10434-021-11045-3.
Tonello, M., Baratti, D., Sammartino, P., Di Giorgio, A., Robella, M., Sassaroli, C., Framarini, M., Valle, M., Macrì, A., Graziosi, L., Coccolini, F., Lippolis, P. V., Roberta, G., Deraco, M., Biacchi, D., Santullo, F., Vaira, M., Di Lauro, K., D'Acapito, F., Carboni, F., Giuffrè, G., Donini, A., Fugazzola, P., Faviana, P., Lorena, S., Scapinello, A., Del Bianco, P., & Sommariva, A. (2021). Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Annals of surgical oncology, . https://doi.org/10.1245/s10434-021-11045-3
Tonello, Marco, et al. "Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)." Annals of surgical oncology vol. (2021). doi: https://doi.org/10.1245/s10434-021-11045-3
Tonello M, Baratti D, Sammartino P, Di Giorgio A, Robella M, Sassaroli C, Framarini M, Valle M, Macrì A, Graziosi L, Coccolini F, Lippolis PV, Roberta G, Deraco M, Biacchi D, Santullo F, Vaira M, Di Lauro K, D'Acapito F, Carboni F, Giuffrè G, Donini A, Fugazzola P, Faviana P, Lorena S, Scapinello A, Del Bianco P, Sommariva A. Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol. 2021 Nov 16; doi: 10.1245/s10434-021-11045-3. Epub 2021 Nov 16. PMID: 34783946.
Copy
Download .nbib